Alerta

INFORMATION PROCESSING DEVICE, IMAGE GENERATION METHOD, AND NON-TRANSITORY COMPUTER-READABLE MEDIUM

Resumen de: US20260253275A1

An information processing device includes a digitizing unit for generating numerical data indicating a time-series change of a biological signal from first image data indicating a waveform of the biological signal, and an image generation unit for generating second image data indicating a waveform of the biological signal by using the generated numerical data. The generated second image data can be used as training data for machine learning or can be used for decision making by a medical worker in diagnosis of a subject to be measured for the biological signal.

AI-DRIVEN MEDICAL INTAKE ASSISTANT

Resumen de: US20260253714A1

An AI-driven medical intake assistant system includes a computing device having a processor and memory configured to execute an intake module, an abnormality detection module, and an electronic health record (EHR) integration module. The intake module presents a conversational interface that dynamically selects patient intake questions using a rule-based branching decision tree with clinical topic tags and transition rules. One or more connected diagnostic devices automatically capture patient vital sign measurements, including blood pressure, temperature, pulse oximetry, or weight, and transmit the measurements to the computing device. The abnormality detection module compares captured measurements to predefined threshold values or historical baseline data retrieved from the EHR and generates provider-facing alerts when deviation thresholds are exceeded. The EHR integration module maps patient responses and vital sign measurements into predefined structured EHR fields prior to a provider consultation.

ELECTROCARDIOGRAM EVALUATION USING Z-SCORE BASED STANDARDS

Resumen de: US20260248436A1

0000 Embodiments include an automated non-invasive method of assessment of an examined subject utilizing an electrocardiogram (ECG) system including: an electronic unit configured to connect to the examined subject, a memory unit configured to contain a database of Z-score-based nomograms of a first set of ECG variables from historic data of healthy individuals, a computer interface system, an adaptive confirmatory enhancement (ACE) module connected to various machine learning algorithms, an oversAIght module with artificial intelligence determining which algorithm to use, and a report generator, the method comprising: determining, by the computer interface system of the ECG system, a disease diagnosis of the examined subject based on a determination that the digital ECG values of the second set of ECG variables of the examined subject are abnormal.

Integrated AI-Powered Wearable Device and Retinal Imaging System for Early Home-Based Screening and Detection of Ocular Tumors

Resumen de: US20260253215A1

The RetinAI invention provides a novel integrated system designed for home-based early screening and detection of ocular tumors and retinal diseases, leveraging advanced artificial intelligence and optical imaging technology. The system comprises a wearable headset with precisely aligned imaging sensors and dual-mode illumination sources for capturing extraocular images to detect leukocoria and intraocular retinal images for direct visualization of tumors, eliminating the need for pharmacological pupil dilation. On-device deep learning models, including representative object detectors and convolutional neural networks, provide real-time diagnostic outputs. Clinical validations demonstrate RetinAI's capability to detect leukocoria as small as 1 mm in diameter and identify a broad spectrum of retinal diseases, confirming its significant potential to enhance ocular health screening, particularly in underserved and resource-limited settings. The cost-effective, user-friendly, and portable nature of the RetinAI system positions it as an essential tool for improving access to ophthalmic care globally.

CUSTOMIZABLE PATIENT MONITORING DEVICE AND SYSTEM

Resumen de: WO2026177966A1

Patient monitoring devices, systems and methods are provided. A customizable patient monitoring device may include multiple ports allowing connection and disconnection of any of various physiological sensors. Signals from physiological sensors may be processed to obtain clinically presentable physiological information, which may include accessing the information from the signals or computing the information based at least in part on the signals. An arrangement of display units may be displayed on a monitoring device display of the customizable patient monitoring device, such as a grid of tiles, in which each tile may display information associated with a specific physiological parameter associated with a specific connected physiological sensor. A tile may be actuated by touch to display an enhanced display on the monitoring device display displaying additional information associated with the specific physiological parameter. The enhanced display may be actuated by touch to provide further information associated with the specific physiological parameter.

PERSONALIZED DIGITAL THERAPEUTICS FOR SKILLS TRAINING USING ROLE-BASED INTERACTIONS

Resumen de: US20260253748A1

Various examples, systems, and methods are disclosed relating to a roleplay pipeline for treatment and skill development. One or more processors can receive, for a roleplay interaction having a defined role for a user and a defined role for a chatbot, content in the roleplay interaction. The one or more processors further can apply the content as input to at least one artificial intelligence (AI) model to cause the at least one AI model to generate an output for the chatbot. The one or more processors further can provide, via a chatbot interface, the output. The digital therapeutic application can improve treatment by providing structured roleplay interactions that support social engagement, strengthen emotion regulation, and improve skill development and can increase the efficacy of the medication that the user is taking to address social skills, emotion skills, behavior challenges, and/or cognitive processing deficits.

CERAMIC SLURRY COMPOSITION FOR PHOTOCURABLE 3D PRINTING

Resumen de: WO2026177311A1

The present invention relates to a ceramic slurry composition for photocurable 3D printing and, more specifically, to a ceramic slurry composition for photocurable 3D printing, which uses a ceramic or glass-ceramic powder, thereby enabling a dental prosthesis to exhibit esthetics similar to natural teeth, and furthermore, comprises a non-reactive diluent, thereby enabling the preparation of a low-viscosity slurry comprising a high content of ceramic or glass-ceramic powder, and in which the slurry thus prepared is easy to mold using 3D printing, and a high-quality three-dimensional molded article can be manufactured upon 3D printing.

VISION-BASED DETECTION OF ACCESS SHEATH

Resumen de: WO2026176271A1

This disclosure provides methods, devices, and systems for controlling robotically assisted medical systems. The present implementations more specifically relate to techniques for vision-based detection of an access sheath. In some aspects, a controller for a medical system obtains a series of images captured by a camera disposed on a distal tip of a medical instrument that is at least partially inserted through an access sheath. The controller infers a respective segmentation mask from each image in the series based on a machine learning model trained to classify each pixel of the image as depicting the access sheath or not depicting the access sheath, where the segmentation mask indicates how many pixels of the image are classified as depicting the access sheath. The controller further determines a position of the distal tip of the instrument relative to the access sheath based on the segmentation masks for the series of images.

Orthodontic device and method

Resumen de: GB2704295A

A dental appliance 20 for correcting jaw relationships, the dental appliance comprising a lower shell for fitting over the lower set of teeth, and an upper shell for fitting over the upper set of teeth. Each of the upper and lower shells comprise a mandibular alteration ridge 42, 44 configured to project occlusally on each side of the shell. Each mandibular alteration ridge comprises at least one guide surface 32, 36 and one or more buttresses 34, 38, wherein a guide surface of a mandibular alteration ridge of the upper shell is configured to engage a guide surface of a mandibular alteration ridge of the lower shell to displace the mandible relative to the maxilla as the jaw closes. A method of correcting a Class II or Class III malocclusion using such an appliance is also disclosed. Figure 2B

MEDICATION DELIVERY SYSTEM

Resumen de: EP4797275A1

A medication delivery system, including a wearable device configured to automatically deliver medication based on food order information received from a user computing device. The medication is delivered via a pump, and the medication may be insulin. The food order information includes timing information and/or information about the food ordered necessary to change a medication delivery. A controller determines a medication adjustment based on an estimated physiological response to the food order information. A delivery pump automatically delivers the medication, e.g., an insulin bolus, prior to or in anticipation of food consumption.

ELECTRONIC DEVICE, AND METHOD FOR OUTPUTTING NOTIFICATION SIGNAL FOR MEDICATION INTAKE BY USING SAME

Resumen de: EP4796098A1

According to an embodiment, the electronic device may comprise a display, a processor, and a memory for storing a medication intake schedule, and instructions. The instructions, when executed by the processor, may cause the electronic device to: display a clock screen including an icon for at least one medication on the basis of the medication intake schedule; identify a notification time for the intake of the at least one medication on the basis of the medication intake schedule; identify an adjustment condition for a medication intake-related notification signal on the basis of the identified notification time; adjust an output time point of the notification signal for the intake of the at least one medication, on the basis of the identified adjustment condition of the medication intake-related notification signal; and display a visual effect corresponding to the icon included in the clock screen, on the basis of the adjusted output time point. Various other embodiments may be possible.

SYSTEMS, DEVICES, COMPONENTS AND METHODS FOR DETECTING THE LOCATIONS OF SOURCES OF CARDIAC RHYTHM DISORDERS IN A PATIENT'S HEART

Resumen de: EP4797280A2

0001 Disclosed are various examples and embodiments of systems, devices, components and methods configured to detect a location of a source of at least one cardiac rhythm disorder in a patient's heart. In some embodiments, electrogram signals are acquired from a patient's body surface, and subsequently normalized, adjusted and/or filtered, followed by generating a two-dimensional spatial map, grid or representation of the electrode positions, processing the amplitude-adjusted and filtered electrogram signals to generate a plurality of three-dimensional electrogram surfaces corresponding at least partially to the 2D map, one surface being generated for each or selected discrete times, and processing the plurality of three-dimensional electrogram surfaces through time to generate a velocity vector map corresponding at least partially to the 2D map. The resulting velocity vector map maybe employed to classify a patient as one of an A-type patient, a B-type patient, and a C-type patient, and to guide therapy subsequently delivered to the patient. Trained atrial discriminative machine learning models that facilitate the foregoing systems and methods, and that provide predictions or results concerning a patient's condition, are also disclosed.

DEVICES AND RELATED METHODS FOR VENTILATION

Resumen de: EP4796155A2

Provided herein are devices and methods that relate to ventilation and respiration. In one embodiment, a ventilator device comprising a fluidic amplifier with one or more coaxially aligned components, where there are no internal moving components. In another embodiment, a device and related methods for treating a patient who needs ventilation such as after infection by the coronavirus Covid-19.

METHOD FOR PRODUCING PATIENT-OPTIMISED DOSAGE FORMS

Resumen de: ZA202307295B

The present application relates to methods of personalised pharmaceutics. More specifically, the invention relates to methods for the production of pharmaceutical dosage forms, which are produced by 3D and/or 2D printing, whereby a wide variety of parameters relevant to the administration of the dosage form can be changed depending on the analysis of patient- and disease-specific data and can be adapted in the course of the patient's treatment. In this way, the quality of treatment for the patient can be improved in the future and significantly increased from the point of view of patient safety.

POLYOXAZOLIDONE DERIVATIVES AND THEIR USE IN MEDICAL DEVICES

Resumen de: EP4541837A1

The invention provides poly(hydroxy oxazolidone) compounds (PHOx) corresponding to following formula (I) or formula (II):whereinR_1', R_2', independently of one another each denote a C1 to C20 alkyl group, preferably a C1 to C10 alkyl group, more preferably a C1 to C3 alkyl group, most preferably a methyl group, and- R₃, R₄ independently of one another each denote hydrogen or a C1 to C20 alkyl group, preferably a C1 to C10 alkyl group, more preferably a C1 to C3 alkyl group, most preferably a methyl group, and- R₅, R_5', R₆, R_6', independently of one another each denote hydrogen or a C1 to C20 alkyl group, preferably a C1 to C10 alkyl group, more preferably a C1 to C3 alkyl group, most preferably a methyl group, or an aryl group, preferably a phenyl group, and- A is an organic linking group selected from a linear, branched, saturated, unsaturated, cyclic and/or non-cyclic aliphatic, aromatic or araliphatic hydrocarbon group, preferably having 1 to 20, more preferably 1 to 12, most preferably 1 to 8 carbon atoms and optionally further containing one or more functional groups selected from ether, ester, amide, amine, carboxyl, sulfur, halogen and/or urethane, and- Optionally A, R₃ and R₄ in formula (I) are linked to each other to form a cyclic structure, and- Optionally R₅ and R_5', and/or R₆ and R_6' in formula (II) are respective

RESIN COMPOSITION FOR STEREOLITHOGRAPHY

Resumen de: EP4796568A1

0001 The present invention provides a resin composition for stereolithography that exhibits excellent strength, toughness, water resistance, and stress retention in the shaped article while reducing the amount of leachables. The present invention relates to a resin composition for stereolithography comprising a monofunctional methacrylic polymerizable compound having a plurality of independent aromatic rings (A), a polyfunctional (meth)acrylic polymerizable compound (B), and a photopolymerization initiator (C).

SYSTEM MAINTAINANCE TECHNIQUES

Resumen de: WO2025088603A1

A service providing apparatus is disclosed comprising a service platform configured for movement along a path having one or more object treatment zones, each object treatment zone comprising equipment configured to apply one or more treatment processes to surface areas of objects carried by one or more objects' platforms along said path. At least one service providing unit is mounted on the service support platform for applying one or more service procedures to the equipment of at least one of the one or more object treatment zones while the support platform is located within the at least one treatment zone, to thereby apply the one or more service procedures while the one or more objects' platforms are located along the path.

A SHRINKING AND SETTING BIOINK

Resumen de: WO2025099720A1

Provided is a hybrid hydrogel composition and methods for its preparation and use in 3D printing biomaterials for tissue engineering applications. The hybrid hydrogel composition comprises discrete hydrogel particles of a first crosslinked polymeric network, interpenetrated- through and threaded by a second crosslinked polymeric network, dispersed in a medium. The first polymer is a thermo-responsive polymer, while the second is a protein-based thermo¬ denaturing polymer. The process for preparing this composition involves mixing swelled hydrogel nanoparticles of the first polymer with a non-crosslinked hydrogel of the second polymer in the presence of a crosslinking agent for the first polymer. The 3D printing method utilizes this composition below the LCST of the thermo-responsive polymer, followed by temperature increase wherein the second polymer cures and fixes the printed ink. This approach enables the creation of high-resolution structures, including artificial tissues with capillary blood vessels, featuring dimensions less than 50 μm.

ORAL PRODUCTS, THREE-DIMENSIONAL PRINTERS USED FOR FORMING ORAL PRODUCTS, AND THREE-DIMENSIONAL PRINTING METHODS FOR FORMING ORAL PRODUCTS

Resumen de: WO2025111344A1

A method of making an oral product includes printing a first product portion of an oral product using of a three-dimensional printer. The first product portion has a first composition. The method further includes printing a second product portion of the oral product using the three-dimensional printer, the second product portion having a second composition different from the first composition, the first product portion and the second product portion defining distinct, non-mixed regions of the oral product.

NEBULISER

Resumen de: EP4796149A1

0001 The present invention provides a nebuliser (100) comprising one or more inputs (110), and a plurality of droplet ejectors (126) in fluid communication with the one or more inputs (110). Each droplet ejector comprises a nozzle portion and a piezoelectric actuator. The one or more inputs are for receiving one or more liquids. Each nozzle portion defines a nozzle outlet in fluid communication with the one or more inputs. Each piezoelectric actuator is operable to cause ejection of a liquid received by one of the one or more inputs through the respective nozzle outlet as one or more droplets. The nebuliser is configured to generate an aerosol comprising the respective one or more droplets ejected by one or more of the plurality of droplet ejectors. At least 50%, by mass, of the droplets of the aerosol have a diameter of at least 5 x 10<-6> m.

A METHOD FOR VOLUMETRIC PRINTING A DENTAL COMPONENT BY PHOTOPOLYMERIZATION OF A PHOTOCURABLE RESIN

Resumen de: EP4796291A1

0001 A method for volumetric printing a dental component by photopolymerization of a photocurable resin.

一种用于骨组织修复的增韧型PLGA/P34HB复合材料及其制备方法

Resumen de: CN122624747A

本发明公开一种用于骨组织修复的增韧型PLGA/P34HB复合材料及其制备方法，属于生物可降解功能材料的技术领域。该复合材料由聚(乳酸‑乙醇酸共聚物)(PLGA)、聚(3‑羟基丁酸‑4‑羟基丁酸共聚物)(P34HB)和γ‑缩水甘油醚氧硅丙基倍半氧烷(POSS)经无溶剂熔融共混制得；POSS与PLGA和P34HB端基原位反应形成共价界面，实现P34HB纳米级均匀分散；复合材料断裂伸长率提升至100%以上，保持良好刚度和强度，无溶剂残留，生物相容性优良，适用于熔融挤出3D打印制备骨修复支架，可用于口腔相关骨缺损修复。

A DEVICE AND METHOD FOR ANALYZING EMOTIONS AND HUMAN RELATIONSHIPS USING COLORS AND A COMPUTER PROGRAM THEREFOR

Resumen de: US20260245265A1

Disclosed is a device and method for analyzing an emotion and a human relationship based on a color. The device includes a display; and a processor electrically connected to the display, wherein the processor is configured to: display an application for analyzing an emotion and a human relationship based on a color on the display; identify a color corresponding to a user, a color corresponding to an age group of the user, a color corresponding to each of emotions of the user, and a color corresponding to an acquaintance of the user as input from the user through the displayed application; extract RGB values of each of the identified colors, convert the extracted RGB values into three-dimensional color coordinates, and display the converted three-dimensional color coordinates on the application.

一种3D打印工艺制作的颅骨矫形固定器

Resumen de: CN224671675U

本实用新型提出一种3D打印工艺制作的颅骨矫形固定器，包括前片壳体和后片壳体，所述前片壳体和后片壳体的顶部均设有端部开口的凹槽结构，当所述前片壳体和后片壳体通过连接结构连接后，所述前片壳体和后片壳体的顶部的凹槽结构的开口处连通，用于放置皮筋，以此加强所述前片壳体和后片壳体连接的稳定性，同时防止在连接结构失效后，还能够通过凹槽结构与皮筋的配合方式使得所述前片壳体和后片壳体不至于完全脱离患者头颅，同时，前片壳体和后片壳体的顶部密封可以防止颅骨长出去并且能够加固整个颅骨矫形固定器的结构强度，从而可以使得颅骨矫形固定器的壁厚做薄，减轻重量。

一种含芳基吡啶盐的光固化3D打印树脂及制备方法和应用

Nº publicación: CN122627973A 25/08/2026

Solicitante:

成都贝施美医疗科技股份有限公司

Resumen de: CN122627973A

本发明涉及新材料技术领域，具体涉及一种含芳基吡啶盐的光固化3D打印树脂及制备方法和应用。具体技术方案为：本发明将可光固化吡啶盐活性单体、光引发剂、活性稀释剂、丙烯酸酯类低聚物、添加剂均匀混合得到3D打印树脂，并将其用于义齿基托的打印。本发明方法反应充分，工艺相对简单，易于实现，可根据需求设计不同结构的含芳基吡啶盐光固化树脂，且少量添加即可表现出极佳的抗菌性。